<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1210167</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2023.1210167</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Insights in lipids, membranes and membranous organelles</article-title>
<alt-title alt-title-type="left-running-head">Ye</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2023.1210167">10.3389/fmolb.2023.1210167</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ye</surname>
<given-names>Jin</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1549569/overview"/>
</contrib>
</contrib-group>
<aff>
<institution>Department of Molecular Genetics</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line>Dallas</addr-line>, <addr-line>TX</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1242859/overview">Mikhail Bogdanov</ext-link>, University of Texas Health Science Center at Houston, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jin Ye, <email>jin.ye@utsouthwestern.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>10</volume>
<elocation-id>1210167</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>04</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Ye.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Ye</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Mol. Biosci." xlink:href="https://www.frontiersin.org/researchtopic/34200" ext-link-type="uri">Editorial on the Research Topic <article-title>Insights in lipids, membranes and membranous organelles</article-title>
</related-article>
<kwd-group>
<kwd>membranes</kwd>
<kwd>lipids</kwd>
<kwd>lipid protein interaction</kwd>
<kwd>membrane protein</kwd>
<kwd>ERAD (ER associated protein degradation)</kwd>
<kwd>protein carbonylation</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>subtitle</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The boundary of a cell and subcellular organelles within it are defined by membranes, which are composed of lipids and proteins. This Research Topic illustrates the critical importance of lipid-protein interactions in targeting and regulation of membrane proteins. Membrane proteins are categorized into peripheral-associated and intrinsic transmembrane proteins. For peripheral membrane proteins, their localization on membranes is primarily determined through their interaction with the hydrophilic head groups of phospholipids or other lipids on membrane surface. In this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.1040106/full">Peters et al.</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.1080161/full">Capelluto et al.</ext-link> depict the structural details of the interaction between these proteins and membranes containing phosphatidylserine or sulfatide, a glycosphingolipid that contains a sulfate moiety in the hydrophilic head group. In contrast, the interaction between intrinsic transmembrane proteins and hydrophobic interiors of membranous lipids is critical for insertion of these proteins into membranes. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.986602/full">Nishikawa et al.</ext-link> in this Research Topic illustrate how a glycolipid in <italic>E. Coli</italic> facilitates this interaction to catalyze integration of these proteins into membranes.</p>
<p>The localization of some proteins on membranes is more important for their regulations than functions. One such example is 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR), which catalyzes the rate limiting step in cholesterol biosynthesis pathway for production of sterols and nonsterol isoprenoids (<xref ref-type="bibr" rid="B3">Goldstein and Brown, 1990</xref>). HMGCR contains a cytosolic catalytic domain at the C-terminus and a membrane-anchoring domain at the N-terminus. The catalytic domain by itself is completely functional without association with membranes; However, the presence of the N-terminal domain allows the degradation of HMGCR to be regulated by lipid products of the enzyme (<xref ref-type="bibr" rid="B2">Gil et al., 1985</xref>). HMGCR is subject to ER-associated degradation, a two-step process consisting ubiquitination followed by extraction of the ubiquitinated proteins from ER membranes to cytosol for proteasomal degradation (<xref ref-type="bibr" rid="B5">Oikonomou and Hendershot, 2020</xref>). In this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.1006822/full">Faulkner and Jo</ext-link> illustrate how sterols and a nonsterol isoprenoid accelerate degradation of HMGCR at the ubiquitination and extraction step, respectively.</p>
<p>While the regulation of HMGCR by lipids is important for normal cell physiology, other protein-lipid interactions may have pathological consequences. One such example is protein carbonylation in diseases such as Alzheimer&#x2019;s disease that is associated with oxidative stress (<xref ref-type="bibr" rid="B4">Manoharan et al., 2016</xref>), which leads to peroxidation of polyunsaturated fatty acids. The breakdown of lipid peroxidation products generates reactive aldehydes such as 4-hydroxy-2-nonenal (HNE), which covalently modifies proteins nonenzymatically through protein carbonylation (<xref ref-type="bibr" rid="B1">Fritz and Petersen, 2011</xref>). In this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.1063632/full">Yamashima et al.</ext-link> describe how HNE-modified Hsp70.1 leads to lysosomal membrane damage.</p>
<p>In summary, the Research Topic of articles in this Research Topic is variation of a theme on lipid-protein interactions. Publication of this Research Topic, hopefully, will stimulate further research in this interesting field.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>JY wrote the manuscript. If the author has included a statement such as &#x201c;I wrote this article&#x201d; &#x201c;I am the author of this manuscript&#x201d; the statement should be changed to the recommended one and a query posted to the author on the proof.All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="s2">
<title>Conflict of interest</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritz</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>D. R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Exploring the biology of lipid peroxidation-derived protein carbonylation</article-title>. <source>Chem. Res. Toxicol.</source> <volume>24</volume>, <fpage>1411</fpage>&#x2013;<lpage>1419</lpage>. <pub-id pub-id-type="doi">10.1021/tx200169n</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gil</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Faust</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme</article-title>. <source>Cell</source> <volume>41</volume>, <fpage>249</fpage>&#x2013;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(85)90078-9</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldstein</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Regulation of the mevalonate pathway</article-title>. <source>Nature</source> <volume>343</volume>, <fpage>425</fpage>&#x2013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1038/343425a0</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manoharan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guillemin</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Abiramasundari</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Essa</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Akbar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akbar</surname>
<given-names>M. D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The role of reactive oxygen species in the pathogenesis of alzheimer&#x27;s disease, Parkinson&#x27;s disease, and huntington&#x27;s disease: A mini review</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2016</volume>, <fpage>8590578</fpage>. <pub-id pub-id-type="doi">10.1155/2016/8590578</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oikonomou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hendershot</surname>
<given-names>L. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Disposing of misfolded ER proteins: A troubled substrate&#x27;s way out of the ER</article-title>. <source>Mol. Cell Endocrinol.</source> <volume>500</volume>, <fpage>110630</fpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2019.110630</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>